Be
Stock
Your Best Stock
Home
Stock Quotes
Markets
Stock Analysis
Broker Reviews
About
Stocks
›
Infectious Disease
›
PFE
Pfizer
PFE
US equity
Market cap rank #98
CAR-T Therapy
Infectious Disease
Cancer Research
$28.49
+$0.31
(+1.10%)
Market open · Sep 24, 2:00 pm ET
After hours $28.19
+0.02%
Open
$28.20
Prev close
$28.18
Day range
$28.20 – $28.85
Volume
19.67M
Market cap
$162.38B
P/E (TTM)
37.5
Dividend yield
6.04%
Overview
Technicals
Financials
Earnings
Valuation
Analysts
Dividends
Options
Ownership
News
Profile
Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations With 21 Air After Miami Crash | Pfizer ...
Dow Jones · 14 Sep 2026
HSBC Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $30
Market news · 10 Sep 2026
Guggenheim Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $31
Market news · 7 Aug 2026
Scotiabank Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $30
Market news · 24 Aug 2026
Pfizer (PFE.US) Sees Signs of Recovery! New Drug Revenue Surges 18%, but Patent Cliff Remains the Biggest Challenge
Zhitong Finance · 24 Aug 2026
Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $29
Market news · 21 Aug 2026
4: Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
SEC · 11 Jun 2026
Pfizer | 4: Statement of changes in beneficial ownership of securities-Director LITTMAN DAN R.
SEC · 28 Apr 2026
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
SEC · 6 Mar 2026
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
SEC · 4 Mar 2026
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
SEC · 28 Feb 2026
Scroll to Top